
About Mabtree Biologics India Private Limited
Data last updated:
Mabtree Biologics India Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 16 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2019PTC132087. Its GSTIN is 36AAMCM6063E1ZC (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Alexander Ratna Monica and Subramanian.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lab F8 First Floor Turkapally Mnihub Mn Park Shameerpet Ranga Reddy, Hyderabad, Telangana, India – 500078.
As per the financials filed for FY 2023, the company reported a revenue of ₹41,511, a decline of 96% compared to the previous year. For the same year it recorded a net loss of ₹77,054 (net margin -185.6%) and EBITDA of ₹25,933 (EBITDA margin 62.5%). Revenue has declined at a compounded annual rate (CAGR) of 75% over three years.
The company is associated with 1 brand: MAbTree.
For more details, the company can be reached via its website mabtree.com.
Company details
Recognitions & Rankings of Mabtree Biologics India
Contact details
Mabtree Biologics India Private Limited's registered office is in Hyderabad, Telangana. Its website is mabtree.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressLab F8 First Floor Turkapally Mnihub Mn Park Shameerpet Ranga Reddy, Hyderabad, Telangana, India – 500078
- IndustryLife Sciences, Biotechnology
To see the full contact details of Mabtree Biologics India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Mabtree Biologics India operates one associated brand: MAbTree. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops innovative monoclonal antibody technologies for cancer treatment. | mabtree.com |
Business activity
The main business activity of Mabtree Biologics India is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Mabtree Biologics India Private Limited, buy the company report.
Financials of Mabtree Biologics India Private Limited
FY 2025 filings availableMabtree Biologics India Private Limited reported revenue of ₹41,511 (down 96% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 75% over three years, including a 96% fall in the latest year. EBITDA rose 122% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹25,933 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹77,054 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 62.5% | |||
| Net Profit Margin | -185.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Mabtree Biologics India Private Limited, buy the company report.
Board of directors of Mabtree Biologics India Private Limited
Mabtree Biologics India has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alexander Ratna Monica | Director | 30 Aug 2019 | 7 Years 2 Months | Current |
| Subramanian Also directs: Docit Syrl India (OPC) Private Limited | Director | 18 Mar 2020 | 6 Years 8 Months | Current |
Peer comparison
Mabtree Biologics India Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biologics, Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genophe Biotech Private Limited | ₹44,240 (FY 2024) | -97.0% | Bangalore, Karnataka, India | |||
| Aeka Biochemicals Private Limited | ₹42,373 (FY 2024) | -92.0% | Thiruvananthapuram, Kerala, India | |||
| Igy Immunologix India Private Limited | ₹42,000 (FY 2025) | -98.0% | Hyderabad, Telangana, India | |||
| Mabtree Biologics India Private Limitedthis company | ₹41,511 (FY 2023) | -₹77,054 | -185.6% | -96.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mabtree Biologics India Private Limited, buy the company report.
Auditor
Mabtree Biologics India Private Limited is audited by M A KANDASAMI & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M A KANDASAMI & ASSOCIATES | FY 2020 | 016172S |
Shareholding
The shareholding of Mabtree Biologics India Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mabtree Biologics India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mabtree Biologics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mabtree Biologics India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mabtree Biologics India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCM6063E1ZC | Telangana | Active | 20 Jun 2019 |
To see the full GST registrations and return filing status of Mabtree Biologics India Private Limited, buy the company report.
Recent activity
Mabtree Biologics India Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Manasa Mahathi Madasu ceased to be Director on 28 Feb 2022.
Frequently asked questions
Mabtree Biologics India is an active private limited company based in Hyderabad, Telangana, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 16 April 2019 (7+ years old) and is registered under CIN U24239TG2019PTC132087.
Mabtree Biologics India has 2 current directors:
- Alexander Ratna Monica - Director
- Subramanian - Director
The latest financial statements of Mabtree Biologics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Mabtree Biologics India is 36AAMCM6063E1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Mabtree Biologics India is U24239TG2019PTC132087. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mabtree Biologics India was incorporated on 16 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Mabtree Biologics India by revenue are Genophe Biotech Private Limited, Aeka Biochemicals Private Limited, Igy Immunologix India Private Limited, all in the Biotechnology industry (Biologics, Biotechnology), with the same principal business activity (scientific research and development).
Manasa Mahathi Madasu ceased to be Director on 28 Feb 2022. Karnati Ankith ceased to be Director on 12 Jun 2020. Subramanian was appointed as Director on 18 Mar 2020. Mabtree Biologics India has 5 board changes on record in total.
Yes, Mabtree Biologics India is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Mabtree Biologics India can be reached through the website mabtree.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Mabtree Biologics India is at Lab F8 First Floor Turkapally Mnihub Mn Park Shameerpet Ranga Reddy, Hyderabad, Telangana, India – 500078.

